Research map: Tailoring pH-responsive charge-conversional interfaces in ionizable lipid-based nanoliposomes for synchronized co-delivery and synergistic therapy of triple-negative breast cancer

Back to the article

Papers in this map

  1. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery · Jung Soo Suk · 2015 · 4532 citations · Cited by this paper
  2. 2-deoxy-d-ribose: A multifaceted player at the crossroads of cancer metabolism · 2026 · Related
  3. Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease · Giampaolo Bianchini · 2016 · 3204 citations · Cited by this paper
  4. Activity-dependent metabolic vulnerability in the APPPS1 Alzheimer’s disease mouse model during isoflurane anesthesia · 2026 · Related
  5. Tumor targeting via EPR: Strategies to enhance patient responses · Susanne K. Golombek · 2018 · 1277 citations · Cited by this paper
  6. Preserved motor function and prolonged sensory local anesthesia with novel PLGA microparticles co-encapsulating lidocaine and capsaicin · 2026 · Related
  7. Nanodrug Delivery: Is the Enhanced Permeability and Retention Effect Sufficient for Curing Cancer? · Yuko Nakamura · 2016 · 1106 citations · Cited by this paper
  8. Iron–quercetin complex induces ex vivo proteomic remodeling in circulating proangiogenic cells derived from human peripheral blood mononuclear cells · 2026 · Related
  9. Doxorubicin-induced cardiotoxicity: An update on the molecular mechanism and novel therapeutic strategies for effective management · Pushkar Singh Rawat · 2021 · 910 citations · Cited by this paper
  10. Acetonic extract of Saskatoon berry attenuates amyloid-associated neurotoxicity in cellular and Drosophila melanogaster Alzheimer’s disease models · 2026 · Related
  11. Triple negative breast cancer: Pitfalls and progress · Paola Zagami · 2022 · 848 citations · Cited by this paper
  12. Design of sunflower trypsin inhibitor 1 derived probes targeting the LDLR and evaluation of their brain delivery · 2026 · Related
  13. Doxorubicin—An Agent with Multiple Mechanisms of Anticancer Activity · Mateusz Kciuk · 2023 · 818 citations · Cited by this paper
  14. The chalcone derivative DN-053 attenuates renal fibrosis and inhibits p38 MAPK and STAT3 signaling in renal fibroblasts · 2026 · Related
  15. Doxorubicin, DNA torsion, and chromatin dynamics · Fan Yang · 2013 · 715 citations · Cited by this paper
  16. Urinary biomarkers in muscle-invasive bladder cancer: Current state and open opportunities for neoadjuvant chemotherapy response prediction and patient stratification · 2026 · Related
  17. Tumor microenvironment: Challenges and opportunities in targeting metastasis of triple negative breast cancer · K.G.K. Deepak · 2020 · 631 citations · Cited by this paper
  18. Fluorinated isoindolinone–amino acid hybrids possessing antiproliferative and antitumor activity in vitro and in vivo · 2026 · Related
  19. Review on Epidermal Growth Factor Receptor (EGFR) Structure, Signaling Pathways, Interactions, and Recent Updates of EGFR Inhibitors · Dima A. Sabbah · 2020 · 601 citations · Cited by this paper
  20. O-GlcNAc transferase as an oncogenic regulator in hematologic malignancies: Mechanisms, disease contexts, and therapeutic perspectives · 2026 · Related
  21. Analysis of anticancer drugs: A review · Susanne Nussbaumer · 2011 · 571 citations · Cited by this paper
  22. Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer · Feng Ye · 2023 · 556 citations · Cited by this paper
  23. Metastatic and triple-negative breast cancer: challenges and treatment options · Sumayah Al-Mahmood · 2018 · 541 citations · Cited by this paper
  24. Underlying the Mechanisms of Doxorubicin-Induced Acute Cardiotoxicity: Oxidative Stress and Cell Death · Chun‐Yan Kong · 2021 · 417 citations · Cited by this paper
  25. Triple-negative breast cancer: is there a treatment on the horizon? · Hui Yao · 2016 · 416 citations · Cited by this paper
  26. Cytosolic delivery of nucleic acids: The case of ionizable lipid nanoparticles · Michele Schlich · 2021 · 384 citations · Cited by this paper
  27. Exploration and insights into the cellular internalization and intracellular fate of amphiphilic polymeric nanocarriers · Samrat Mazumdar · 2021 · 295 citations · Cited by this paper
  28. Doxorubicin and other anthracyclines in cancers: Activity, chemoresistance and its overcoming · Roberto Mattioli · 2023 · 295 citations · Cited by this paper
  29. A review of nanotechnology-based approaches for breast cancer and triple-negative breast cancer · Vikas Kumar Jain · 2020 · 291 citations · Cited by this paper
  30. Role of oxidative stress and inflammation-related signaling pathways in doxorubicin-induced cardiomyopathy · Saixian Shi · 2023 · 234 citations · Cited by this paper
  31. Ionizable lipid nanoparticles for in utero mRNA delivery · Rachel Riley · 2021 · 225 citations · Cited by this paper
  32. Mechanisms of doxorubicin-induced drug resistance and drug resistant tumour growth in a murine breast tumour model · Claudia Christowitz · 2019 · 207 citations · Cited by this paper
  33. Effects of morphology and size of nanoscale drug carriers on cellular uptake and internalization process: a review · Wenjie Zhang · 2022 · 199 citations · Cited by this paper
  34. Co-delivery of doxorubicin and erlotinib through liposomal nanoparticles for glioblastoma tumor regression using an in vitro brain tumor model · Sushant Lakkadwala · 2018 · 193 citations · Cited by this paper
  35. Risk of Treatment-Related Toxicities from EGFR Tyrosine Kinase Inhibitors: A Meta-analysis of Clinical Trials of Gefitinib, Erlotinib, and Afatinib in Advanced EGFR -Mutated Non–Small Cell Lung Cancer · Pei N. Ding · 2016 · 173 citations · Cited by this paper
  36. Erlotinib and the Risk of Oral Cancer · William N. William · 2015 · 159 citations · Cited by this paper
  37. Insight Into Nanoliposomes as Smart Nanocarriers for Greening the Twenty-First Century Biomedical Settings · Katya M. Aguilar-Pérez · 2020 · 155 citations · Cited by this paper
  38. Glut1 promotes cell proliferation, migration and invasion by regulating epidermal growth factor receptor and integrin signaling in triple-negative breast cancer cells · Sunhwa Oh · 2017 · 149 citations · Cited by this paper
  39. Evaluation of propylene glycol nanoliposomes containing curcumin on burn wound model in rat: biocompatibility, wound healing, and anti-bacterial effects · Nooshin Kianvash · 2017 · 135 citations · Cited by this paper

Source: OpenAlex (CC0)